Biologicals I
Course, Master's level, 3FB028
Autumn 2023 Autumn 2023, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 28 September 2023–29 October 2023
- Language of instruction
- English
- Entry requirements
-
150 credits, including 90 credits in biomedicine, pharmaceutical science, chemistry, natural science and/or engineering. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 17 April 2023
- Application code
- UU-39218
Admitted or on the waiting list?
- Registration period
- 22 September 2023–29 September 2023
- Information on registration from the department
Spring 2024 Spring 2024, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 15 January 2024–15 February 2024
- Language of instruction
- English
- Entry requirements
-
150 credits, including 90 credits in biomedicine, pharmaceutical science, chemistry, natural science and/or engineering. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 16 October 2023
- Application code
- UU-89218
Admitted or on the waiting list?
- Registration period
- 8 January 2024–15 January 2024
- Information on registration from the department
Autumn 2024 Autumn 2024, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 3 October 2024–3 November 2024
- Language of instruction
- English
- Entry requirements
-
150 credits, including 90 credits in biomedicine, pharmaceutical science, chemistry, natural science and/or engineering. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 15 April 2024
- Application code
- UU-39218
Admitted or on the waiting list?
- Registration period
- 25 September 2024–3 October 2024
- Information on registration from the department
Spring 2025 Spring 2025, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 20 January 2025–20 February 2025
- Language of instruction
- English
- Entry requirements
-
150 credits, including 90 credits in biomedicine, pharmaceutical science, chemistry, natural science and/or engineering. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 15 October 2024
- Application code
- UU-89218
Admitted or on the waiting list?
About the course
The course deals with how antibodies (proteins) can be used as drugs. You will learn more about how to design antibodies with the goal of improving the treatment of a particular disease. You will also gain insight into how to use these protein drugs today and how to work on improving their functionality for future therapy areas.